Allogene Therapeutics ALLO SEC Filings

NASDAQ ALLO
$2.00 +0.02 (+1.01%)
As of: Sep 4, 2026 · 1:04 PM EDT
EDGAR Disclosures

Regulatory Filings

Source SEC EDGAR

Every regulatory document Allogene Therapeutics, Inc. (ALLO) has filed with the SEC, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

# Form Type Form Group Accession Date Filing Index